Expert Opinion on Therapeutic Targets

Cathelicidins and functional analogues as antisepsis molecules
pp. 993-1004(12)
Authors: Mookherjee, Neeloffer; Rehaume, Linda M; Hancock, Robert EW

TIM-3 as a therapeutic target in human inflammatory diseases
pp. 1005-1009(5)
Author: Anderson, David E

Suppressing renal NADPH oxidase to treat diabetic nephropathy
pp. 1011-1018(8)
Authors: Tojo, Akihiro; Asaba, Kensuke; Onozato, Maristela L

A final common pathway for depression: implications for therapy
pp. 1019-1032(14)
Author: Stone, Eric A

Targeted therapies in small-cell lung cancer
pp. 1033-1041(9)
Authors: Fernainy, Khaled; Saba, Nabil

Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved
pp. 1043-1053(11)
Authors: López-Lázaro, Miguel

Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling
pp. 1055-1069(15)
Authors: Hagland, Hanne; Nikolaisen, Julie; Hodneland, Linn I; Gjertsen, Bjøorn T; Bruserud, Øystein; Tronstad, Karl J

The non-genomic crosstalk between PPAR-γ ligands and ERK1/2 in cancer cell lines
pp. 1071-1085(15)
Authors: Papageorgiou, Efstathia; Pitulis, Nea; Msaouel, Pavlos; Lembessis, Peter; Koutsilieris, Michael

Small-molecule modulators of Hh and Wnt signaling pathways
pp. 1087-1101(15)
Authors: Kiselyov, Alex S; Tkachenko, Sergey E; Balakin, Konstantin V; Ivachtchenko, Alexandre V

P-selectin
pp. 1103-1117(15)
Authors: Ludwig, Ralf J; Schön, Michael P; Boehncke, Wolf-Henning

MicroRNAs as therapeutic targets in human diseases
pp. 1119-1129(11)
Authors: Jeyaseelan, Kandiah; Herath, Wishva B; Armugam, Arunmozhiarasi